A lot of news on the research front in July, which can only be good. It’s a joy, relief as well as hope that one of those research projects or trials might lead to longer periods of remission, and perhaps a return to lesser disability for those with primary and secondary forms of multiple sclerosis. So let’s keep fingers, toes, eye lashes and anything else crossed that can be crossed. A lot of people with severe MS deserve at least that. Remember, 2.3 million people with MS globally is staggering. It doesn’t have to be that way, though.
- Human Stem Cells Effectively Treat Multiple Sclerosis in Mice Models
HCPLive – Embryonic stem cells are a potentially viable treatment option for multiple sclerosis (MS), according to research published online in Stem Cell Reports.
- Innovative research tool pinpoints potential therapies for multiple sclerosis
Medical Xpress – Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100.
- Melanocortin Receptor Agonist can Treat Multiple Sclerosis
HCPLive – FRIDAY, July 11, 2014 (HealthDay News) — Melanocortin receptor type 3 (MC3) has protective properties for joint and periodontal tissues.
- Researchers discover neuroprotective role of immune cell
Medical Xpress – A type of immune cell widely believed to exacerbate chronic adult brain diseases, such as Alzheimer’s disease and multiple sclerosis (MS).
- UCSF scientists identify drugs that could help MS patients
SFGate – In patients with multiple sclerosis, the immune system attacks myelin, the insulation that surrounds the wire-like connections between nerve cells.
- Scientists 1 step closer to cell therapy for multiple sclerosis patients
Medical Xpress – In multiple sclerosis, the protective covering of axons, called myelin, becomes damaged and lost.
- MS Genzyme Drug Lemtrada Approved in Argentina, Still Under Review in US
Multiple Sclerosis News Today – Genzyme Lemtrada, a drug produced by Genzyme for the treatment of adult patients suffering from relapsing remitting multiple sclerosis (RRMS).
- Actavis Plans Generic Version of Acorda’s Multiple Sclerosis Drug Ampyra
Multiple Sclerosis News Today – Acorda Therapeutics recently announced receiving a notice letter from pharmaceutical company Actavis Plc indicating their plans to commercialize Ampyra.
- SMC Says Yes to Lemtrada(R)a- 1/4 (alemtuzumab) 12mg IV, a New Treatment for Adults with …
MarketWatch – “Scotland has one of the highest rates of multiple sclerosis in the world, and the approval of Lemtrada in Scotland is an important step forward.
- Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 8700 for Treatment of Multiple …
MarketWatch – Multiple sclerosis (MS) is an unpredictable, often disabling disease of the central nervous system (CNS), which interrupts the flow of information.
Medical treatment news
- Wonder drug that eases multiple sclerosis side effects
Express.co.uk – Since being diagnosed with multiple sclerosis (MS) in 2003 there have been times when Linda Elsegood has felt her life so hopeless.
- Medicines containing cannabis set to go on sale
RTE.ie – The move means sufferers of Multiple Sclerosis will soon be able to legally use Sativex, an oral spray containing cannabis extracts.
- Medicinal cannabis to be made available by prescription for MS sufferers
Irish Mirror – Cannabis is to be provided under prescription for sufferers of Multiple Sclerosis, under a new revision to current laws making the drug illegal.
- Tysabri Protects Against Relapse in Multiple Sclerosis, According To Study
Multiple Sclerosis News Today – Tysabri According to a study published in JAMA Neurology, multiple sclerosis patients are greatly benefited by Biogen Idec’s Tysabri (natalizumab).
- NICE green light for Biogen’s oral MS drug
PMLiVE – UK patients with multiple sclerosis (MS) are set to have another oral treatment option following last week’s recommendation for Biogen Idec’s Tecfidera.
- PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of …
MarketWatch – PLEGRIDY is a subcutaneous injectable therapy for relapsing-remitting multiple sclerosis (RRMS), in which interferon beta-1a is pegylated.
- Massage therapy can alleviate symptoms of multiple sclerosis
News-Medical.net – An estimated 2.3 million people worldwide live with multiple sclerosis (MS) each day, a debilitating disease that can often cause severe pain.
- Low Vitamin D is Linked to Severe Acute Optic Neuritis in Multiple Sclerosis
Multiple Sclerosis News Today – vitamin D metabolism For the approximately 15-20% of multiple sclerosis patients with acute optic neuritis (AON), lack of vitamin D.
©Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2014. Unauthorised use and/or duplication of this material without express and written permission from this blog’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.